Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs.

导出 LinkOut

翻译打印收藏纠错

作者： Jennifer H,Lofland ^[1] ; Phaedra T,Johnson ^[2] ; Mike P,Ingham ^[3] ; Sarah C,Rosemas ^[2] ; John C,White ^[2] ; Lorie,Ellis ^[3]

作者单位： Janssen Global Commercial Strategic Organization - Immunology, Raritan, NJ. ^[1] Health Economics and Outcomes Research, Optum Inc., Eden Prairie, MN. ^[2] Health Economics and Outcomes Research, Janssen Scientific Affairs, LLC, Raritan, NJ, USA. ^[3]

关键词 autoimmune disease biologic therapy cross-sectional survey shared decisionmaking

DOI 10.2147/PPA.S133222

PMID 28572722

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览35

Patient preference and adherence

2017年11卷

947-958页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

检索历史清除